Smartee Expands Pediatric Orthodontic Education Initiatives in Asia Pacific Through Clinical Exchange
SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- Smartee Denti-Technology recently brought together dental professionals for the Smartee Kinder & Teen Workshop, an educational program focused on the clinical assessment and management of growing patients. Held under the theme "Children's Early Orthodontic Treatment: From Screening to Clinical Application," the workshop provided a platform for clinicians to discuss practical considerations in pediatric orthodontics, including...
HEC Group Enters Strategic Partnerships in Macau to Advance the Internationalization of Cordyceps Sinensis
MACAU, Sept. 2, 2026 /PRNewswire/ -- HEC Group has entered into strategic partnerships with MCCY Science & Greater Health Manufactory (operating regionally as Seed Scientific Research International Limited) and Longtai Health to strengthen the production, commercialization and international development of HEC life+ 東陽光鮮蟲草. Representatives from HEC Group Health and Wellness...
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system
AUSTIN, Texas, Sept. 2, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the nation to participate in a clinical trial to evaluate the safety and effectiveness of a next-generation mapping and pulsed field ablation system to treat patients with paroxysmal and persistent atrial fibrillation. Andrea Natale, M.D.,...
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that would support new product reimbursement and broaden access to...
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
MILPITAS, Calif., Sept. 2, 2026 /PRNewswire/ -- Zepp Health Corporation (NYSE: ZEPP) ("Zepp", the "Company" or "we") today announced its unaudited financial results for the second quarter of 2026. Second Quarter of 2026 Financial and Operating Highlights: Revenue reached US$63.5 million, representing year-over-year growth of 6.9%. Gross margin was 37.4%, an increase of 1.2 percentage points from the...
Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026
Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) showcased a portfolio of automated and digital solutions spanning key pharmaceutical R&D, production and quality control workflows at the ISPE Singapore Conference & Exhibition 2026, one of...
Super MOXI® by Sciton Ushers in a New Era of Head-to-Toe Skin Revitalization
PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- Sciton Inc., a pioneer and leader in medical and aesthetic laser and light-based technologies, today announced the launch of Super MOXI® with High Density (HD) Delivery™, a major evolution of its award-winning MOXI® laser that brings new speed, versatility, and possibilities to one...
THE SKIN OF COLOR SOCIETY (SOCS) UNITES 21 GLOBAL ORGANIZATIONS TO ADVANCE SKIN OF COLOR DERMATOLOGY
CHICAGO, Sept. 1, 2026 /PRNewswire/ -- The Skin of Color Society (SOCS) announces the SOCS Global Council, a strategic initiative unifying leaders from 22 international dermatology organizations who share a mission to advance skin of color dermatology. The Global Council aims to: Foster international collaboration and knowledge-sharing. Address challenges...
Suki Named a Transformational Innovation Leader in Ambient Clinical Intelligence by Frost & Sullivan
2026 recognition highlights Suki's innovation, clinical quality and measurable impact as Ambient Clinical Intelligence expands across the enterprise SAN ANTONIO, Sept. 1, 2026 /PRNewswire/ -- Suki, the leader in Ambient Clinical Intelligence (ACI), has been recognized by Frost & Sullivan with its 2026 North American Transformational Innovation Leadership Recognition for Suki's innovation in clinical AI, quality of clinical...
REJURAN COSMETICS Expands Across Canada with Nationwide Sephora Launch
Premium derma-cosmetic brand from PharmaResearch, the Korean pharmaceutical company behind the globally recognized REJURAN® skin booster available in more than 50 countries, will launch in Sephora Canada stores. SEOUL, South Korea, Sept. 1, 2026 /PRNewswire/ -- REJURAN COSMETICS, the premium derma-cosmetic brand developed by PharmaResearch, the South Korean pharmaceutical company behind the globally recognized REJURAN® PN-based skin booster available...
